Pharmacological effects of MDL 11,939: A selective, centrally acting antagonist of 5-HT2 receptors
β Scribed by Mark W. Dudley; Norbert L. Wiech; Francis P. Miller; Albert A. Carr; Hsien C. Cheng; Lawrence E. Roebel; Niall S. Doherty; Henry I. Yamamura; Richard C. Ursillo; Dr. Michael G. Palfreyman
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 723 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0272-4391
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Zatosetron is a potent, orally active 5βHT~3~ receptor antagonist with a long duration of activity in laboratory animals and humans. Several metabolites have been detected in plasma and urine of humans and experimental animals receiving zatosetron. The present study was designed to expl
The two enantiomers of the title compound have been prepared by different synthetic routes. Both bind strongly to 5-HTlA receptors from rat forebrain membrane tissue. However, in a guinea pig ileum preparation, the (R)enantiomer exhibits properties consistent with its being an agonist, whereas the (
In some psychiatric disorders 5-HT 2A receptors play an important role. In order to investigate those in vivo there is an increasing interest in obtaining a metabolically stable, subtype selective and high affinity radioligand for receptor binding studies using positron emission tomography (PET). Co